Impact of Antiretroviral Therapy on AIDS-Related Mortality in Nigeria: A Longitudinal Study (2010-2023)

Title

Impact of Antiretroviral Therapy on AIDS-Related Mortality in Nigeria: A Longitudinal Study (2010-2023)

Authors

1. uthman Al-ameen, University of Ibadan, Scientist, Nigeria

Abstract

Background: AIDS-related death continues to be a significant public health challenge in Nigeria. The availability of Antiretroviral Therapy has altered the prevalence of HIV/AIDS from a fatal disease to a manageable disease all over the world. This research examines the effect of Antiretroviral Therapy (ART) coverage on AIDS-related death in Nigeria for the year 2010-2023. The study aimed to assess the correlation between ART coverage and AIDS-related death in Nigeria.

Methods: This research employs the secondary data analysis research method. ART coverage and AIDS-related death statistics from the year 2010 to 2023 were obtained from UNAIDS

Results: The calculated correlation between ART coverage and AIDS-related death in Nigeria was statistically significant and negative, with Pearson correlation coefficient r = - 0.976. This shows that, with improving ART coverage, AIDS-related death is reduced.

This study established a perfect negative relationship between ART coverage and AIDS-related death in Nigeria for the years 2010-2023 with a Pearson correlation coefficient (r) of (-0.976).

Conclusion: The results of this study point to the fact that ART is helpful in the reduction of AIDS-related deaths in Nigeria. HIV treatment using ART must continue to increase through enhanced health systems to ensure better delivery of services and through targeted interventions that will further reduce AIDS-related deaths and improve the overall health of the population.

Keywords

Mortality Nigeria.

PDF

This browser does not support PDFs. Please download the PDF to view it: View the PDF.

Conclusion

This study establishes the life-saving influence that ART has had in decreasing AIDS-related mortality across Nigeria between the years 2010 and 2023. The negative coefficient (r = -0.976, p < 0.001) confirms that AIDS-related deaths have decreased while ART coverage has improved. During the study period, there was a gradual increase in the availability of ART, which was proven to have significantly reduced causes of death as a result of HIV/AIDS.

This process works by boosting immunity, decreasing the viral load, and preventing the onset of other infections, which in turn would increase the life span and quality of life of people who are infected with HIV. All these benefits make ART an important tool in patient management and in the control of the epidemic. However, the author is aware of other interfering factors that could also lead to a decline in mortality such as an increase in the overall healthcare services offered, better diagnostic methods, and other improvements within the health system that may affect mortality.

The policy implications are clear. Consequently, continued efforts to scale up treatment with ART are crucial. This includes addressing issues such as inadequate funding, lack of access to healthcare, especially in rural areas, and stigma-related issues. The following steps should be the combination of ART delivery with primary healthcare and focusing on the patients who are at risk of being left behind. Future studies should focus on understanding the role of socioeconomic factors and other predictors, which will aid in developing more effective ART interventions, thereby enhancing the impact of ART programs in Nigeria.

The limitation of this study is that it provides Nigeria-specific results, and therefore, may not be generalizable to other countries with different health systems or epidemic patterns.

The study recommends that the government and stakeholders provide ART and make it more accessible to the people, especially in rural areas, and that ART services be incorporated into primary healthcare.

Reference

1. 1. HIV.gov. (2023). Global HIV statistics. Retrieved November 27, 2024, 2. UNAIDS. (2023). Global HIV and AIDS statistics. Retrieved November 27, 2024. 3. Tanser, F., Lesueur, D., Solarsh, G., & Wilkinson, D. (2000). HIV heterogeneity and proximity of homestead to roads in rural South Africa: An exploration using a geographical information system. Tropical Medicine & International Health, 5(4), 40. 4. Odimegwu, C. O., Alabi, O., De Wet, N., & Akinyemi, J. O. (2018). Ethnic heterogeneity in the determinants of HIV/AIDS stigma and discrimination among Nigerian women. BMC Public Health, 18(1), 5668. 5. Ogunmola, O. J., Oladosu, Y. O., & Olamoyegun, M. A. (2014). Relationship between socioeconomic status and HIV infection in a rural setting. HIV/AIDS - Research and Palliative Care. Retrieved March 29, 2022 6. Lewis, J. J., Ronsmans, C., Ezeh, A., & Gregson, S. (2004). The population impact of HIV on fertility in sub-Saharan Africa. AIDS (London, England), 18(Suppl 2), S35–S43. 7. Weiser, S. D., Heisler, M., Leiter, K., et al. (2006). Routine HIV testing in Botswana: A population-based study on attitudes, practices, and human rights concerns. PLoS Medicine, 3(7), e261. https://doi.org/10.1371/journal.pmed.0030261 8. Kalichman, S. C., & Simbayi, L. C. (2003). HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in Cape Town, South Africa. Sexually Transmitted Infections, 79(6), 442–447. 9. World Health Organization (WHO). (2024, July 22). HIV: Antiretroviral therapy (ART). Retrieved November 23, 2024, 10. UNAIDS. (2024). Global HIV & AIDS statistics — Fact sheet. Retrieved November 23, 2024 11. Swendeman, D., Ingram, B. L., & Rotheram-Borus, M. J. (2009). Common elements in self-management of HIV and other chronic illnesses: An integrative framework. AIDS Care, 21(10), 1321–1334. 12. Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., et al. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. The New England Journal of Medicine, 365(6), 493–505. 13. Tanser, F., Bärnighausen, T., Grapsa, E., Zaidi, J., & Newell, M. L. (2013). High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science, 339(6122), 966–971. 14. Boden, D., Hurley, A., Zhang, L., et al. (1999). HIV-1 drug resistance in newly infected individuals. JAMA, 282(12), 1135–1141. 15. Hecht, F. M., Grant, R. M., Petropoulos, C. J., et al. (1998). Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. The New England Journal of Medicine, 339(5), 307–311. 16. Doherty, M., Ford, N., Vitoria, M., Weiler, G., & Hirnschall, G. (2013). The 2013 WHO guidelines for antiretroviral therapy: Evidence-based recommendations to face new epidemic realities. Current Opinion in HIV and AIDS, 8(6), 528–534. 17. Buh, A., Deonandan, R., Gomes, J., Krentel, A., Oladimeji, O., & Yaya, S. (2022). Adherence barriers and interventions to improve ART adherence in Sub-Saharan African countries: A systematic review protocol. PLOS ONE, 17(6), e0269252. https://doi.org/10.1371/journal.pone.0269252 18. Bassey, A. E., & Miteu, G. D. (2023). A review of current trends in HIV epidemiology, surveillance, and control in Nigeria. Annals of medicine and surgery (2012), 85(5), 1790–1795. 19. O’BRIEN-CARELLI C, STEUBEN K, STAFFORD KA, ALIOGO R, ALAGI M, et al. (2022) Mapping HIV prevalence in Nigeria using small area estimates to develop a targeted HIV intervention strategy. PLOS ONE 17(6): e0268892. 20. Odeny, T. A., Penner, J., Lewis-Kulzer, J., Leslie, H. H., Shade, S. B., Adero, W., Kioko, J., Cohen, C. R., & Bukusi, E. A. (2013). Integration of HIV Care with Primary Health Care Services: Effect on Patient Satisfaction and Stigma in Rural Kenya. AIDS research and treatment, 2013, 485715 21. Santosa, A., Wall, S., Fottrell, E., Högberg, U., & Byass, P. (2014). The development and experience of epidemiological transition theory over four decades: a systematic review. Global health action, 7, 23574. 22. Adepoju P. (2019). APIN: a history of HIV management in Nigeria. The lancet. HIV, 6(6), e353. 23. Salomon, A., Law, S., Johnson, C., Baddeley, A., Rangaraj, A., Singh, S., & Daftary, A. (2022). Interventions to improve linkage along the HIV-tuberculosis care cascades in low- and middle-income countries: A systematic review and meta-analysis. PloS one, 17(5), e0267511 24. Klaas, N. E., Thupayagale-Tshweneagae, G., & Makua, T. P. (2018). The role of gender in the spread of HIV and AIDS among farmworkers in South Africa. African journal of primary health care & family medicine, 10(1), e1–e8. 25. Burkey, M. D., Weiser, S. D., Fehmie, D., Alamo-Talisuna, S., Sunday, P., Nannyunja, J., Reynolds, S. J., & Chang, L. W. (2014). Socioeconomic determinants of mortality in HIV: evidence from a clinical cohort in Uganda. Journal of acquired immune deficiency syndromes (1999), 66(1), 41–47. 26. Ibiloye, O., Decroo, T., Masquillier, C., Jwanle, P., Okonkwo, P., van Olmen, J., Lynen, L., & Van Belle, S. (2022). Outcomes of a community-based antiretroviral therapy programme for key populations living with HIV in Benue State, Nigeria: protocol for a realist evaluation. BMJ open, 12(11), e062941.

Author Contribution

The author was solely responsible for all aspects of this work, including conceptualization, data collection, analysis, and manuscript preparation

Funding

This Research was self Funded

Software Information

The data analysis for this study was performed using IBM SPSS Statistics, version (27.0)

Conflict of Interest

The author declares that there is no conflict of interest

Acknowledge

The author would like to express gratitude to the UNAIDS organization for providing the data set used for the study.

Data availability

The data used in this study were obtained from UNAIDS, as detailed in the manuscript. For further information on data access, please refer to UNAIDS at [https://aidsinfo.unaids.org/].